Company profile: Dyadic
1.1 - Company Overview
Company description
- Provider of microbial protein production platforms and bio-based chemicals. Offers the C1 Platform for developing and manufacturing vaccines, antibodies, and therapeutic proteins for human and animal health; the Dapibus Platform for rapid, large-scale non-pharmaceutical proteins for food and nutrition; recombinant HSA, alpha-lactalbumin, and transferrin; and the DYAI-100 COVID-19 vaccine candidate.
Products and services
- Dapibus Platform: Engineers a microbial protein production platform enabling rapid development and large-scale manufacture of proteins for food and nutrition applications, custom-engineered for non-pharmaceutical workflows
- C1 Protein Production Platform: Builds a microbial platform for developing and producing vaccines, antibodies, and therapeutic proteins for human and animal health, scalable for end-to-end biomanufacturing
- DYAI-100 COVID-19 Vaccine Candidate: Develops a recombinant protein vaccine using the C1 platform, aimed at providing immunity against COVID-19 for human health, candidate-stage
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Dyadic
Arzeda
HQ: United States
Website
- Description: Provider of AI-driven protein and enzyme design and manufacturing for pharmaceuticals, industrial chemicals, and food applications. Offers Intelligent Protein Design Technology to create novel proteins; ProSweet enzymes for efficient production of Reb D and Reb M from stevia; and collaborates with Unilever (cleaning), W. L. Gore (materials), Takeda (therapeutic biologics), and AAK (plant-based oils).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Arzeda company profile →
Enlight Biosciences
HQ: United States
Website
- Description: Provider of technology platforms and software, including Entrega for enabling oral delivery of complex biological molecules and drug substances, KNODE for connecting users with experts and their content within and beyond R&D organizations, and Peerin, a Twitter application that helps professionals discover industry-specific insights by identifying and ranking high-value conversations and trends.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Enlight Biosciences company profile →
Comecer
HQ: Italy
Website
- Description: Provider of protection technologies in nuclear medicine, isolation, and nuclear power plant equipment, and of screening systems for special applications serving hospitals, universities, industrial groups, and research organizations. Products include aseptic processing and containment systems, a Terbium-161 production line, the IRIS radiopharmaceutical injection system, THERABED protected admission management, ISP radioactive waste management, and dose calibrators.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Comecer company profile →
Irvine Scientific
HQ: United States
Website
- Description: Provider of cell culture media, reagents, and medical devices for researchers and clinicians in bioproduction, vaccines, cell and gene therapies, regenerative medicine, and assisted reproductive technologies. Products include chemically defined CHO, NK, and T cell media, embryo culture oil, DMSO-free cryopreservation, and bone marrow culture media.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Irvine Scientific company profile →
SAW Instruments
HQ: Germany
Website
- Description: Provider of innovative analytical systems for the life sciences market, enabling label-free analysis of molecular biomolecular interactions and combining stability, ease of use, and high sensitivity; develops, manufactures, and sells equipment for life sciences applications.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full SAW Instruments company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Dyadic
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Dyadic
2.2 - Growth funds investing in similar companies to Dyadic
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Dyadic
4.2 - Public trading comparable groups for Dyadic
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →